» Articles » PMID: 17476328

Association of Killer Cell Immunoglobulin-like Receptor Genes with Hodgkin's Lymphoma in a Familial Study

Abstract

Background: Epstein-Barr virus (EBV) is the major environmental factor associated with Hodgkin's lymphoma (HL), a common lymphoma in young adults. Natural killer (NK) cells are key actors of the innate immune response against viruses. The regulation of NK cell function involves activating and inhibitory Killer cell Immunoglobulin-like receptors (KIRs), which are expressed in variable numbers on NK cells. Various viral and virus-related malignant disorders have been associated with the presence/absence of certain KIR genes in case/control studies. We investigated the role of the KIR cluster in HL in a family-based association study.

Methodology: We included 90 families with 90 HL index cases (age 16-35 years) and 255 first-degree relatives (parents and siblings). We developed a procedure for reconstructing full genotypic information (number of gene copies) at each KIR locus from the standard KIR gene content. Out of the 90 collected families, 84 were informative and suitable for further analysis. An association study was then carried out with specific family-based analysis methods on these 84 families.

Principal Findings: Five KIR genes in strong linkage disequilibrium were found significantly associated with HL. Refined haplotype analysis showed that the association was supported by a dominant protective effect of KIR3DS1 and/or KIR2DS1, both of which are activating receptors. The odds ratios for developing HL in subjects with at least one copy of KIR3DS1 or KIR2DS1 with respect to subjects with neither of these genes were 0.44[95% confidence interval 0.23-0.85] and 0.42[0.21-0.85], respectively. No significant association was found in a tentative replication case/control study of 68 HL cases (age 18-71 years). In the familial study, the protective effect of KIR3DS1/KIR2DS1 tended to be stronger in HL patients with detectable EBV in blood or tumour cells.

Conclusions: This work defines a template for family-based association studies based on full genotypic information for the KIR cluster, and provides the first evidence that activating KIRs can have a protective role in HL.

Citing Articles

Natural killer cells and their exosomes in viral infections and related therapeutic approaches: where are we?.

Razizadeh M, Zafarani A, Taghavi-Farahabadi M, Khorramdelazad H, Minaeian S, Mahmoudi M Cell Commun Signal. 2023; 21(1):261.

PMID: 37749597 PMC: 10519079. DOI: 10.1186/s12964-023-01266-2.


The impact of HLA polymorphism on herpesvirus infection and disease.

Palmer W, Norman P Immunogenetics. 2023; 75(3):231-247.

PMID: 36595060 PMC: 10205880. DOI: 10.1007/s00251-022-01288-z.


KIR in Allogeneic Hematopoietic Stem Cell Transplantation: Need for a Unified Paradigm for Donor Selection.

Dhuyser A, Aarnink A, Peres M, Jayaraman J, Nemat-Gorgani N, Rubio M Front Immunol. 2022; 13:821533.

PMID: 35242134 PMC: 8886110. DOI: 10.3389/fimmu.2022.821533.


Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma.

Jiang P, Nolte I, Hepkema B, Stulp M, van den Berg A, Diepstra A Front Immunol. 2022; 13:829943.

PMID: 35154153 PMC: 8828906. DOI: 10.3389/fimmu.2022.829943.


Association of gene polymorphisms with Type 1 Diabetes: a meta-analysis.

Soltani S, Mostafaei S, Aslani S, Farhadi E, Mahmoudi M J Diabetes Metab Disord. 2021; 19(2):1777-1786.

PMID: 33520861 PMC: 7843782. DOI: 10.1007/s40200-020-00569-2.


References
1.
Williams F, Meenagh A, Sleator C, Middleton D . Investigation of killer cell immunoglobulinlike receptor gene diversity: I. KIR2DL4. Hum Immunol. 2004; 65(1):31-8. DOI: 10.1016/j.humimm.2003.10.009. View

2.
Pappworth I, Wang E, Rowe M . The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing. J Virol. 2006; 81(2):474-82. PMC: 1797427. DOI: 10.1128/JVI.01777-06. View

3.
Thorley-Lawson D, Gross A . Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004; 350(13):1328-37. DOI: 10.1056/NEJMra032015. View

4.
Gandhi M, Tellam J, Khanna R . Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol. 2004; 125(3):267-81. DOI: 10.1111/j.1365-2141.2004.04902.x. View

5.
Cartwright R, Watkins G . Epidemiology of Hodgkin's disease: a review. Hematol Oncol. 2004; 22(1):11-26. DOI: 10.1002/hon.723. View